Publications by authors named "Adel Hajj-Ali"

Background & Aims: Pancreatitis is the most common serious adverse event associated with endoscopic retrograde cholangiopancreatography (ERCP). This meta-analysis aimed to precisely assess the risk factors for post-ERCP pancreatitis (PEP).

Methods: We searched electronic databases for studies that assessed risk factors for PEP after adjusting for ≥3 risk factors, including at least one pre-specified patient-related and one procedure-related risk factor, and reported the data as adjusted odds ratios (ORs) with 95% confidence intervals.

View Article and Find Full Text PDF

Background: Apical hypertrophic cardiomyopathy (aHCM) is a distinct variant characterized by predominant hypertrophy of the left ventricle apex.

Objectives: This study sought to describe aHCM patients' characteristics and develop a risk score for aHCM patients.

Methods: A total of 462 patients (age 58 ± 15 years, 68% male) diagnosed with aHCM were included.

View Article and Find Full Text PDF
Article Synopsis
  • The study looked into why some people have a hard time preparing their bowels for a colonoscopy, which is a procedure to check inside the intestines.
  • Researchers found 48 different factors that might make it harder for people to prepare, including age, health conditions, and some medications.
  • Understanding these risk factors can help doctors predict who might struggle with bowel preparation, making colonoscopies easier and saving money on extra tests.
View Article and Find Full Text PDF

Background: The risk of metachronous advanced colorectal neoplasia (mACRN) in young adults with advanced lesions at baseline colonoscopy is not well defined.

Aims: To examine the risk for (mACRN) in adults <50 years old who had advanced neoplasia (AN) at baseline colonoscopy and determine factors associated with mACRN in these patients.

Method: Patients 18 to 49 years of age with ≥1 AN [tubular adenoma (TA) ≥10 mm or with villous features or high-grade dysplasia (HGD), sessile serrated lesion (SSL) ≥10 mm or with dysplasia, traditional serrated adenoma (TSA)] on baseline colonoscopy between 2011 and 2021 who had surveillance colonoscopy >6 months after their baseline examination were included.

View Article and Find Full Text PDF

Introduction: Following ileocolic resection (ICR), the clinical importance and prognostic implications of histologic activity on biopsies in Crohn's disease (CD) patients with endoscopic remission are not well defined. The aim of this study was to determine if histologic activity in patients with endoscopic remission is associated with future risk of endoscopic and/or radiologic postoperative recurrence (POR).

Methods: In this multicenter retrospective cohort study, adult patients with CD who underwent ICR between 2009 and 2020 with endoscopic biopsies of ileal mucosa from Rutgeerts i0 on index colonoscopy were included.

View Article and Find Full Text PDF
Article Synopsis
  • Mavacamten is approved for treating symptomatic obstructive hypertrophic cardiomyopathy (oHCM) and aims to improve left ventricular outflow tract gradients and reduce the need for septal reduction therapy (SRT).
  • A study of 150 patients showed significant improvements in New York Heart Association (NYHA) class and reduced LVOT gradients after 12 weeks of mavacamten treatment, with 46% of patients showing at least one class improvement.
  • Although there was a slight decline in left ventricular ejection fraction (LVEF), no patients required SRT or experienced severe heart failure complications during the study period.
View Article and Find Full Text PDF

Goals: Assess the outcomes of various therapeutic regimens to treat initial endoscopic postoperative recurrence despite biologic prophylaxis.

Background: Postoperative biologic prophylaxis reduces postoperative Crohn's disease (CD) recurrence rates. Optimal treatment strategies for endoscopic recurrence have not been elucidated.

View Article and Find Full Text PDF
Article Synopsis
  • - Hypertrophic cardiomyopathy (HCM) is a heart disease that can look different from person to person and is caused by genes.
  • - One of the main problems with HCM is that part of the heart can get too thick, which can block blood flow.
  • - There haven't been many new medicines for HCM, but now there's a new kind of drug that could help treat the disease better.
View Article and Find Full Text PDF

Background & Aims: Preoperative risk stratification may help guide prophylactic biologic utilization for the prevention of postoperative Crohn's disease (CD) recurrence; however, there are limited data exploring and validating proposed clinical risk factors. We aimed to explore the preoperative clinical risk profiles, quantify individual risk factors, and assess the impact of biologic prophylaxis on postoperative recurrence risk in a real-world cohort.

Methods: In this multicenter retrospective analysis, patients with CD who underwent ileocolonic resection (ICR) from 2009 to 2020 were identified.

View Article and Find Full Text PDF

Introduction: Hypertrophic cardiomyopathy (HCM), a phenotypically variable disorder with a genetic basis, was first described in the late 1800s. Since the discovery of the disease, various medical and surgical treatments have been proposed with surgical treatments proving to be of more benefit than medical in patients with severe symptoms. Although beta blockers, calcium channel blockers, and disopyramide have been used for their negative inotropic effect, the data behind utilization of these medications is weak at best.

View Article and Find Full Text PDF

In a large screening program of asymptomatic middle-aged individuals, we sought to assess the degree of risk reclassification provided by comparing multiethnic study on subclinical atherosclerosis coronary artery calcium scoring (CACS) versus atherosclerotic cardiovascular disease (ASCVD) and Reynolds risk score (RRS) score. All 5,324 consecutive patients (aged 57 ± 8 years, 76% male) who underwent CACS screening at the Cleveland Clinic as part of a primary prevention executive health between March 16 and October 21 were included. The 10-year ASCVD, RRS, and multiethnic study on subclinical atherosclerosis CACS (MESA-CACS) risk scores were calculated and categorized as <1, 1 to 4.

View Article and Find Full Text PDF

Background: Colonic polyposis of unknown etiology (CPUE) is defined as ≥10 cumulative colonic adenomas without a detectable germline pathogenic variant. Surveillance for patients with >100 adenomas is recommended, similar to patients with familial adenomatous polyposis. The utility of extra-colonic screening in patients with 10 to <100 adenomas is not well established.

View Article and Find Full Text PDF

Purpose: Transthyretin cardiac amyloidosis (ATTR-CA) is thought to be prevalent in patients with severe aortic stenosis (AS) who are referred for transcatheter aortic valve replacement (TAVR). However, prior studies were published when TAVR was only offered to elderly, inoperable, and high-risk patients. The aim of this study was to reevaluate the prevalence of ATTR-CA in a contemporary TAVR population and identify high-risk features to guide referral for technetium-99 pyrophosphate scan (99mTc-PyP scan) screening.

View Article and Find Full Text PDF

Hypertrophic cardiomyopathy (HCM) is a common heridetary cardiac disorder characterized by a wide range of symptoms. The pharmacological treatment of HCM is currently limited to beta blockers, non-dihydropyridine calcium channel blockers and disopyramide. Mavacamten is a novel cardiac myosin inhibitor, which was recently added to the limited pharmacological list of treatment options for HCM.

View Article and Find Full Text PDF

Introduction: Surgical management of Crohn's disease (CD) is common. Postoperative complications include anastomotic stricturing (AS). The natural history and risk factors for AS have not been elucidated.

View Article and Find Full Text PDF

Venous thromboembolism (VTE) is a serious complication commonly experienced in cancer patients. Incidence of VTE typically brings poor prognosis as it represents the second most common cause of mortality in cancer patients just after the malignancy itself. Studies suggest that multiple myeloma (MM) is among the malignancies with further enhanced risk of VTE, especially in patients undergoing autologous hematopoietic cell transplantation (AHCT).

View Article and Find Full Text PDF

Background: Neuroendocrine carcinomas are extremely rare in the esophagus as they represent less than 0.04% of all neuroendocrine tumors. To date, only 14 cases of poorly differentiated, high-grade esophageal NEC have been described in the literature.

View Article and Find Full Text PDF
Article Synopsis
  • Bladder cancer treatment costs a lot, and the outlook for advanced cases isn’t great, so researchers wanted to see what’s being studied worldwide about it.
  • They looked at research papers from 2000 to 2020, finding almost 20,000 important articles, mostly from 20 countries, especially the USA and China.
  • The review showed that while there's a lot of interest in surgery and pathology, less is known about things like radiotherapy and palliative care, pointing to areas where more research and money are needed.
View Article and Find Full Text PDF

Background: The model for end-stage liver disease (MELD) has been widely used to predict the mortality and morbidity of various surgical procedures.

Objectives: We aimed to correlate a high preoperative MELD score with adverse 30-day postoperative complications following radical cystectomy.

Design And Methods: Patients who underwent elective, non-emergency radical cystectomy were identified from the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP) database from 2005 to 2017.

View Article and Find Full Text PDF

Background: Significant tricuspid regurgitation (TR) is associated with poor outcome and high operative mortality resulting from late presentation. Yet, the optimal timing for intervention is unknown.

Objectives: The purpose of this study was to evaluate the prognostic value of echocardiographic parameters to inform early intervention in asymptomatic TR.

View Article and Find Full Text PDF
Article Synopsis
  • Many countries in the Middle East and North Africa have higher levels of pancreatic cancer than the world average, and need better research to help fight it.
  • Researchers looked at over 5,800 studies about pancreatic cancer in these regions, but found that only 1,098 were really useful for understanding the problem.
  • The study showed that most research focuses on diagnosis and treatment, but there are big gaps in public health studies, and not many studies are funded, especially by local sources.
View Article and Find Full Text PDF
Article Synopsis
  • The study looks at prostate cancer research in Arab countries, which is important because more people are getting this disease there.
  • They found 4,142 articles about the topic, but only 874 met their research guidelines.
  • The review shows that while there's more research being done, many areas like prevention and screening are lacking, and most studies haven't been funded or include female authors.
View Article and Find Full Text PDF